Foreword

Woeber, 1992, Thyrotoxicosis and the heart, N Engl J Med, 327, 94, 10.1056/NEJM199207093270206 Oppenheimer, 1991, Thyroid hormone action at the molecular level, 204 Ching, 1996, Cardiac hypertrophy as a consequence of long term thyroxine therapy and thyrotoxicosis, Heart, 75, 363, 10.1136/hrt.75.4.363 Thomas, 1993, Left ventricular filling abnormalities prior to and following treatment of thyrotoxicosis: is diastolic dysfunction implicated in thyrotoxic cardiomyopathy?, Eur Heart J, 14, 662, 10.1093/eurheartj/14.5.662 Ebisawa, 1994, Irreversible cardiomyopathy due to thyrotoxicosis, Cardiology, 84, 274, 10.1159/000176411 Sandler, 1959, The nature and prognosis of heart disease in thyrotoxicosis, QJM, 28, 347 Likoff, 1943, Thyrotoxicosis as the sole cause of heart failure, Am J Med, 206, 425, 10.1097/00000441-194310000-00002 Featherstone, 1983, Angina in thyrotoxicosis, Arch Intern Med, 143, 554, 10.1001/archinte.143.3.554 Reynolds, 1971, Thyrotoxic mitral regurgitation: a probable form of papillary muscle dysfunction, Am J Dis Child, 122, 544, 10.1001/archpedi.1971.02110060114022 Channick, 1981, Hyperthyroidism and mitral valve prolapse, N Engl J Med, 305, 499, 10.1056/NEJM198108273050906 Somerville, 1950, Angina pectoris and thyrotoxicosis, Br Heart J, 12, 245, 10.1136/hrt.12.3.245 Mariotti, 1995, The aging thyroid, Endocr Rev, 16, 686, 10.1210/edrv-16-6-686 Dillman, 1991, The cardiovascular system in thyrotoxicosis, 759 Montereggi, 1996, Signal-averaged P-wave duration and the risk of paroxysmal atrial fibrillation in hyperthyroidism, Am J Cardiol, 77, 266, 10.1016/S0002-9149(97)89391-5 Forfar, 1985, Hyperthyroid heart disease, Clin Endocrinol Metab, 14, 491, 10.1016/S0300-595X(85)80044-X Smith, 1994, Systemic embolism in thyrotoxicosis without cardiac arrhythmia, Thyroid, 4, 209, 10.1089/thy.1994.4.209 Culp, 1986, Thyrotoxicosis presenting with secretory diarrhea, Ann Intern Med, 105, 216, 10.7326/0003-4819-105-2-216 Sellin, 1991, The gastrointestinal tract in thyrotoxicosis, 780 Yao, 1989, Cholestatic jaundice in hyperthyroidism, Am J Med, 86, 619, 10.1016/0002-9343(89)90398-7 Freedberg, 1991, The skin in thyrotoxicosis, 731 Ramsay, 1966, Muscle dysfunction in hyperthyroidism, Lancet, 2, 931, 10.1016/S0140-6736(66)90536-8 Bradley, 1971, Neurologic manifestations of thyroid disease, Postgrad Med, 50, 118, 10.1080/00325481.1971.11697595 Ramsay, 1965, Electromyography in thyrotoxicosis, QJM, 34, 255 Ghosh, 1993, Hyperkalemic periodic paralysis associated with thyrotoxicosis, J Assoc Physicians India, 41, 239 Ober, 1972, Thyrotoxic periodic paralysis in the United States, Medicine, 71, 109, 10.1097/00005792-199205000-00001 Swanson, 1981, Neurologic aspects of thyroid dysfunction, 56, 504 Skanse, 1956, Thyrotoxicosis as a cause of cerebral dysrhythmias and convulsive seizures, Acta Endocrinol, 22, 246, 10.1530/acta.0.0220246 Jabbari, 1980, Seizures in thyrotoxicosis, Epilepsia, 21, 91, 10.1111/j.1528-1157.1980.tb04048.x Yang, 1995, MELAS syndrome associated with diabetes mellitus and hyperthyroidism, Clin Endocrinol (Oxf), 43, 235, 10.1111/j.1365-2265.1995.tb01922.x Trzepacz, 1989, The psychiatric manifestations of Graves' disease, Hosp Med, 64 Marumo, 1970, Effect of Ca++ and prostacyclin E1 on vasopressin activation of renal adenyl cyclase, J Clin Invest, 50, 1613, 10.1172/JCI106649 Meema, 1970, Simple radiologic demonstration of cortical bone loss in thyrotoxicosis, Radiology, 97, 9, 10.1148/97.1.9 Grant, 1995, Is previous hyperthyroidism a risk factor for osteoporosis in postmenopausal women?, Clin Endocrinol (Oxf), 43, 339, 10.1111/j.1365-2265.1995.tb02041.x Franklyn, 1995, Effect of estrogen replacement therapy upon bone mineral density in thyroxine treated women with a past history of thyrotoxicosis, Thyroid, 5, 359, 10.1089/thy.1995.5.359 Kung, 1995, Changes in serum lipoprotein (A) and lipids during treatment of hyperthyroidism, Clin Chem, 41, 226, 10.1093/clinchem/41.2.226 Moller, 1996, Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after treatment, Clin Endocrinol (Oxf), 44, 453, 10.1046/j.1365-2265.1996.692514.x O'Meara, 1993, Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism, J Clin Endocrinol Metab, 76, 79, 10.1210/jc.76.1.79 Krass, 1994, Menstrual disturbances in thyrotoxicosis, Clin Endocrinol (Oxf), 40, 641, 10.1111/j.1365-2265.1994.tb03016.x Gordon, 1997, Gynecomastia as the initial manifestation of hyperthyroidism, Endocr Pract, 3, 80, 10.4158/EP.3.2.80 Whishaw, 1939, The diagnosis of thyrotoxicosis with special reference to the masked types, Med J Aust, 1, 785, 10.5694/j.1326-5377.1939.tb114796.x Lahey, 1931, Nonactivated (apathetic) type of hyperthyroidism, N Engl J Med, 204, 747, 10.1056/NEJM193104092041501 McCullagh, 1936, Atypical hyperthyroidism, Med Clin North Am, 19, 1733 Greenwood, 1985, Hyperthyroidism and the impalpable thyroid gland, Clin Endocrinol, 22, 583, 10.1111/j.1365-2265.1985.tb02993.x Dreyfuss, 1984, Protracted epigastric pain and vomiting as a presentation of thyrotoxicosis, J Clin Gastroenterol, 6, 435, 10.1097/00004836-198410000-00008 Coe, 1982, Apathetic thyrotoxicosis presenting as an abdominal emergency, South Med J, 75, 175, 10.1097/00007611-198202000-00014 Lahey, 1931, Apathetic thyroidism, Ann Surg, 93, 1026, 10.1097/00000658-193105000-00008 Charpman, 1956, Bizarre clinical manifestations of hyperthyroidism, N Engl J Med, 254, 1, 10.1056/NEJM195601052540101 Dhar, 1974, Choreoathetosis and thyrotoxicosis, Ann Intern Med, 80, 426, 10.7326/0003-4819-80-3-426_2 Emanulle, 1989, Agoraphobia and hyperthyroidism, Am J Med, 86, 484, 10.1016/0002-9343(89)90353-7 Becker, 1991, Thyrotoxicosis resembles Lyme disease, Ann Intern Med, 114, 914, 10.7326/0003-4819-114-10-914_2 Thomas, 1970, Apathetic thyrotoxicosis: a distinctive clinical and laboratory entity, Ann Intern Med, 72, 679, 10.7326/0003-4819-72-5-679 1970, Lancet, 2, 809 Bayer, 1991, Effective laboratory evaluation of thyroid status, Med Clin North Am, 75, 1, 10.1016/S0025-7125(16)30469-2 Spencer, 1990, Applications of a new chemilumiometric assay to subnormal assessment, J Clin Endocrinol Metab, 70, 453, 10.1210/jcem-70-2-453 Nicoloff, 1990, The use and misuse of the sensitive thyrotropin assays, J Clin Endocrinol Metab, 71, 553, 10.1210/jcem-71-3-553 Hay, 1991, American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays, Clin Chem, 37, 2002, 10.1093/clinchem/37.11.2002 Sarne, 1991, Thyroid function tests, 617 Hennessey, 1995, Evaluation of early (5 to 6 hours) iodine 123 uptake for diagnosis and treatment planning in Graves' disease, Arch Intern Med, 155, 621, 10.1001/archinte.1995.00430060083010 Ashcraft, 1981, Management of thyroid nodules, II: scanning techniques, thyroid suppressive therapy and fine needle aspiration, Head Neck Surg, 3, 297, 10.1002/hed.2890030406 Black, 1972, 99mTc pertechnetate flow study for evaluation of cold thyroid nodules, Radiology, 102, 705, 10.1148/102.3.705 McKenzie, 1989, The clinical use of thyrotropin receptor antibody measurements, J Clin Endocrinol Metab, 69, 1093, 10.1210/jcem-69-6-1093 Grove, 1975, Evaluation of exophthalmos, N Engl J Med, 292, 1005, 10.1056/NEJM197505082921905 Schneider, 1978, Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin antibodies, J Clin Endocrinol Metab, 47, 126, 10.1210/jcem-47-1-126 Graves, 1835, Clinical lectures, London Med Surg, 7, 516 Fisfalen, 1995, Graves' disease and autoimmune thyroiditis, 319 Adams, 1956, Abnormal responses in the assay of thyrotropin, 34, 11 DeGroot, 1989, The causes of autoimmune thyroid disease, Endocr Rev, 10, 537, 10.1210/edrv-10-4-537 Hirota, 1986, Thyroid function and histology in forty five patients with hyperthyroid Graves' disease in clinical remission more than ten years after thionamide drug treatment, J Clin Endocrinol Metab, 62, 165, 10.1210/jcem-62-1-165 Livadas, 1976, Malignant cold thyroid nodules and hyperthyroidism, Br J Surg, 33, 726, 10.1002/bjs.1800630914 Wartofsky, 1991, Differences and similarities in the treatment of Graves' disease in Europe, Japan and the United States, Thyroid, 1, 129, 10.1089/thy.1991.1.129 Greer, 1994, Treating Graves' disease, Endocrinologist, 4, 69, 10.1097/00019616-199401000-00011 Sugrue, 1980, Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases, QJM, 49, 51 Wartofsky, 1973, Low remission after therapy of Graves' disease: possible relation of dietary iodine with antithyroid therapy results, JAMA, 226, 1083, 10.1001/jama.1973.03230090011002 Howard, 1967, Treatment of thyrotoxicosis, JAMA, 202, 706, 10.1001/jama.1967.03130210080013 Hashizume, 1991, Administration of thyroxine in treated Graves' disease: effects of the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism, N Engl J Med, 324, 947, 10.1056/NEJM199104043241403 Landsberg, 1977, Catecholamines and hyperthyroidism, Clin Endocrinol Metab, 6, 697, 10.1016/S0300-595X(77)80076-5 Bahouth, 1994, Genetic regulation of G protein linked receptor expression, 361 Ventrella, 1994, Beta-adrenergic blocking drugs in the management of hyperthyroidism, Endocrinologist, 4, 391, 10.1097/00019616-199409000-00010 Rubenfeld, 1979, Variable plasma propranolol levels in thyrotoxicosis, N Engl J Med, 300, 353, 10.1056/NEJM197902153000707 Cooper, 1991, Treatment of thyrotoxicosis, 897 Feely, 1984, Use of β-adrenoreceptor blocking drugs in hyperthyroidism, Drugs, 27, 425, 10.2165/00003495-198427050-00003 Hertz, 1942, Application of radioactive iodine in the therapy of Graves' disease, J Clin Invest, 21, 64 Beierwaltes, 1978, The treatment of hyperthyroidism with iodine-131, Semin Nucl Med, 8, 95, 10.1016/S0001-2998(78)80010-5 Jarlov, 1995, Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile?, Clin Endocrinol, 43, 325, 10.1111/j.1365-2265.1995.tb02039.x Vormittag, 1982, Structural chromosomal aberrations before and after administration of 20ci of iodine-131, Mutat Res, 105, 333, 10.1016/0165-7992(82)90103-8 Bliddal, 1982, 131I treatment of diffuse and nodular toxic goiter with or without antithyroid agent, Acta Endocrinol (Copenh), 99, 517, 10.1530/acta.0.0990517 McDermott, 1983, Radioiodine induced thyroid storm: case reports and literature review, Am J Med, 75, 353, 10.1016/0002-9343(83)91217-2 Althaus, 1986, HLA-DR3 and DRw6: prognostic factors for the incidence of hypothyroidism in Graves' disease after radioiodine treatment, Acta Endocrinol, 113, 323, 10.1530/acta.0.1130323 Cunnien, 1982, Radioiodine induced hypothyroidism in Graves' disease: factors associated with increased incidence, J Nucl Med, 23, 978 Klementschitsch, 1979, Reemergence of thyroidectomy as treatment for Graves' disease, Surg Clin North Am, 59, 35, 10.1016/S0039-6109(16)41731-7 Gorman, 1983, Temporal relationship between onset of Graves' ophthalmopathy and the diagnosis of thyrotoxicosis, 58, 515 Tamai, 1980, Changes in thyroid functions in patients with euthyroid Graves' disease, J Clin Endocrinol Metab, 50, 108, 10.1210/jcem-50-1-108 Gorman, 1994, Pathogenesis of Graves' ophthalmopathy, Thyroid, 4, 379, 10.1089/thy.1994.4.379 Garrity, 1992, Graves' ophthalmology: an ophthalmologist's perspective, Thyroid Today, 15, 1 Burch, 1993, Graves' ophthalmopathy: current concepts regarding pathogenesis and management, Endocr Rev, 14, 747 Gilbard, 1983, Ocular surface drying and tear film osmolarity in thyroid eye disease, Acta Ophthalmol (Copenh), 61, 108, 10.1111/j.1755-3768.1983.tb01401.x Werner, 1969, Classification of the eye changes of Graves' disease, J Clin Endocrinol Metab, 29, 982, 10.1210/jcem-29-7-982 Tallstedt, 1992, Occurrence of ophthalmopathy after treatment of Graves' hyperthyroidism, N Engl J Med, 326, 1733, 10.1056/NEJM199206253262603 Bartalena, 1989, Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism, N Engl J Med, 321, 1349, 10.1056/NEJM198911163212001 Smith, 1989, Connective tissue, glycosaminoglycans and diseases of the thyroid, Endocr Rev, 10, 366, 10.1210/edrv-10-3-366 Morris, 1988, Clinical utility of thyrotropin receptor antibody assays: comparison of radioreceptor and bioassay methods, 63, 707 Cairns, 1972, Pretibial myxedema, vol 10, 1867 King, 1959, A case study of peculiar soft-tissue and bony changes in association with thyroid disease, J Clin Endocrinol Metab, 19, 1323, 10.1210/jcem-19-10-1323 Plummer, 1913, The clinical and pathologic relationships of hyperplastic and nonhyperplastic goiter, JAMA, 61, 650, 10.1001/jama.1913.04350090018006 Farid, 1994, Molecular basis of thyroid cancer, Endocr Rev, 15, 202 Hamburger, 1987, The autonomously functioning thyroid nodule: Goetsch's disease, Endocr Rev, 8, 439, 10.1210/edrv-8-4-439 Bech, 1977, Subacute thyroiditis de Quervain: a disease associated with HLA B antigen, Acta Endocrinol, 86, 504, 10.1530/acta.0.0860504 Lio, 1984, Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (De Quervain), Acta Endocrinol, 106, 67, 10.1530/acta.0.1060067 Nikolai, 1980, Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis), Arch Intern Med, 140, 478, 10.1001/archinte.1980.00330160038023 Roberton, 1948, Lassitude, coldness and hair changes following pregnancy and their response to treatment with thyroid extract, Br Med J, 2S, 93 Gerstein, 1993, Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus, Ann Intern Med, 118, 419, 10.7326/0003-4819-118-6-199303150-00004 Jansson, 1988, Postpartum thyroiditis, Baillieres Clin Endocrinol Metab, 2, 619, 10.1016/S0950-351X(88)80056-9 Hay, 1985, Thyroiditis: a clinical update, 60, 836 Kourides, 1977, Thyrotropin induced hyperthyroidism: use of alpha and beta subunits to identify patients with pituitary tumors, J Clin Endocrinol Metab, 45, 534, 10.1210/jcem-45-3-534 Bouillon, 1982, Thyroid function in patients with hyperemesis gravidarum, Am J Obstet Gynecol, 148, 922, 10.1016/0002-9378(82)90475-6 Goodwin, 1992, Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects, Am J Obstet Gynecol, 167, 648, 10.1016/S0002-9378(11)91565-8 Goodwin, 1992, The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum, J Clin Endocrinol Metab, 75, 1333, 10.1210/jc.75.5.1333 Galton, 1971, Alterations in thyroid hormone economy in patients with hydatidiform mole, J Clin Invest, 50, 1345, 10.1172/JCI106614 Brennan, 1995, Non-goitrous (Type 1) amiodarone associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo, Thyroid, 5, 177, 10.1089/thy.1995.5.177 Aghini-Lombardi, 1993, Treatment of amiodarone iodine induced thyrotoxicosis with plasmapheresis and methimazole, J Endocrinol Invest, 16, 823, 10.1007/BF03348934 Cavalleri, 1992, Unusual types of thyrotoxicosis, Adv Intern Med, 91, 271 Stange, 1955, Accidental ingestion of poisons, J Pediatr, 47, 470, 10.1016/S0022-3476(55)80058-3 Cohen, 1989, Thyrotoxicosis due to ingestion of excess thyroid hormone, Endocr Rev, 10, 113, 10.1210/edrv-10-2-113 Braunstein, 1986, Unintentional thyrotoxicosis factitia due to a diet pill, West J Med, 145, 388 Ohno, 1971, Clinical observations on thyroidismus medicamentosus due to weight reducing pills in Japan, Endocrinol Jpn, 18, 321, 10.1507/endocrj1954.18.321 Hedberg, 1987, An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef, N Engl J Med, 316, 993, 10.1056/NEJM198704163161605 Mariotti, 1982, Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia, N Engl J Med, 307, 410, 10.1056/NEJM198208123070705 Greer, 1991, Thyrotoxicosis of extra-thyroid origin, 728 Burch, 1993, Life-threatening thyrotoxicosis, Endocrinol Metab Clin North Am, 22, 263, 10.1016/S0889-8529(18)30165-8 Annaise, 1985, Reserpine in propranolol-resistant thyroid storm, Arch Intern Med, 145, 2248, 10.1001/archinte.1985.00360120120020 Ingbar, 1966, Management of emergencies: thyroid storm, N Engl J Med, 274, 1252, 10.1056/NEJM196606022742209 Seely, 1991, Thyrotoxicosis in pregnancy, Endocrinologist, 1, 409, 10.1097/00019616-199112000-00009 Gilnoer, 1990, Regulation of maternal thyroid during pregnancy, J Clin Endocrinol Metab, 71, 276, 10.1210/jcem-71-2-276 Becks, 1991, Thyroid disease and pregnancy, Med Clin NorthArn, 75, 121, 10.1016/S0025-7125(16)30475-8 Davis, 1989, Thyrotoxicosis complicating pregnancy, Am J Obstet Gynecol, 160, 63, 10.1016/0002-9378(89)90088-4 Ramsay, 1983, Thyrotoxicosis in pregnancy: results of therapy by antithyroid drugs combined with T4, Clin Endocrinol, 18, 73, 10.1111/j.1365-2265.1983.tb03188.x Hollingsworth, 1972, Hereditary aspects of Graves' disease in infancy and childhood, J Pediatr, 81, 446, 10.1016/S0022-3476(72)80170-7 Harve, 1962, Pregnancy and thyrotoxicosis, Br Med J, 2, 817, 10.1136/bmj.2.5308.817 Zakarija, 1983, Pregnancy-associated change in thyroid stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism, J Clin Endocrinol Metab, 57, 1036, 10.1210/jcem-57-5-1036 Delange, 1991, effects of maternal thyroid function during pregnancy on fetal development, 7 Edmonds, 1994, Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose, Eur J Endocrinol, 131, 120, 10.1530/eje.0.1310120 Kuo, 1994, Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during and after therapy, Eur J Endocrinol, 131, 125, 10.1530/eje.0.1310125 Tamai, 1995, Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients, J Clin Endocrinol Metab, 80, 1481, 10.1210/jc.80.5.1481 McIver, 1996, Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug, N Engl J Med, 334, 220, 10.1056/NEJM199601253340403